Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Cash Flow-to-Debt Ratio
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow-to-Debt Ratio of 0.28x as of September 2024, meaning its operating cash flow of TL33.37 Million could theoretically repay 0% of its total liabilities (TL120.48 Million) in one year. See ONCSM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow-to-Debt Ratio (2020–2023)
Historical debt coverage capacity for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 4 annual periods. For the full cash flow conversion analysis, see ONCSM cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
Year-by-year debt coverage analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. Check Oncosem Onkolojik Sistemler Sanayi ve Ti cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.36x | TL-38.10 Million | TL106.61 Million | ▼ -185.1% |
| 2022 | 0.42x | TL52.69 Million | TL125.50 Million | ▼ -58.8% |
| 2021 | 1.02x | TL51.68 Million | TL50.75 Million | ▲ +194.4% |
| 2020 | 0.35x | TL19.41 Million | TL56.11 Million | — |